AGN $185.60 +1.39 (0.75%)
Allergan Stock Charts
The 5 year and 1 year stock charts are below.
50 Day Moving Average
The 50 Day Moving Average is at $176.47 which is 5.17% below the stock price of $185.60.
200 Day Moving Average
The 200 Day Moving Average is at 168.01 which is 10.47% below the stock price of $185.60.
Because both the 50 DMA and 200 DMA are below the current stock price, this can be considered a bullish technical indicator.
Notice that the 200 Day Moving Average is crossing upward through the 50 Day Moving Average.
This is called a "Golden Cross" which is an extremely bullish technical analysis chart pattern.
AGN Stock Price
Below are a few key dates for the stock price.
Year To Date
The most recent stock price is $185.60.
The Year To Date (YTD) return is +8.97%.
52 Week Low
The 52 Week Low stock price is $142.81 set on Mon, Mar 5, 2018 which is 168 days ago.
The current price per share is 29.96% above the 52 week low.
52 Week High
The 52 Week High stock price is $237.41 set on Mon, Sep 11, 2017 which is 343 days ago.
The current price per share is -21.82% below the 52 week high.
All Time High
The All Time High stock price is $340.34 set on Wed, Jul 29, 2015 which is 1,118 days ago.
The current price per share is -45.47% below the all time high.
Below is the EPS, P/E Ratio and Earnings Date.
The EPS is -$6.3 and the P/E Ratio is 0.
A negative Earnings Per Share (EPS) means that this company is losing money and not profitable at this time.
Stocks can make big percentage moves on the earnings announcement.
Companies announce earnings either before the market open or after the close.
The Earnings Release Date for Allergan PLC was Mon, Apr 30, 2018.
Since this earnings release 112 days ago, the stock price is up by +14.54%.
Many investors know the importance of a companies earnings report. Also, the market reaction to the earnings release can be even more important and can help in making a prediction of a future price forecast of the shares.
A significant post earnings announcement percentage move can continue or reverse an existing trend for several days or weeks after the earnings date.
The most recent Earnings Release Date was on Thu, Jul 26, 2018, which was 25 days ago.
Since this earnings date, the stock price is up by +4.96%.
Below is important Dividend information.
The Annual Dividend Yield is 1.71%.
(The next ex-dividend date will be around Wed, Nov 14, 2018.)
Investors should understand the dividend history of a company. Dividend history will show the dividend payments disbursed to investors over the years.
|Declaration Date||Amount||Ex-Date||Record Date||Pay Date|
|Mon, Jul 30, 2018||$0.72||Thu, Aug 16, 2018||Fri, Aug 17, 2018||Mon, Sep 17, 2018|
|Fri, May 4, 2018||$0.72||Thu, May 17, 2018||Fri, May 18, 2018||Fri, Jun 15, 2018|
|Mon, Feb 12, 2018||$0.72||Tue, Feb 27, 2018||Wed, Feb 28, 2018||Wed, Mar 28, 2018|
|Fri, Oct 27, 2017||$0.70||Thu, Nov 16, 2017||Fri, Nov 17, 2017||Fri, Dec 15, 2017|
|Wed, Aug 2, 2017||$0.70||Wed, Aug 16, 2017||Fri, Aug 18, 2017||Fri, Sep 15, 2017|
|Fri, May 5, 2017||$0.70||Tue, May 16, 2017||Thu, May 18, 2017||Thu, Jun 15, 2017|
|Wed, Nov 2, 2016||$0.70||Fri, Feb 24, 2017||Tue, Feb 28, 2017||Tue, Mar 28, 2017|
Below are other Biotech & Pharma stocks as Allergan.
AGN Company Profile
Learn more about Allergan.
Allergan PLC is a Health Care stock that trades on the NYSE and has a market capitalization of $62.62 Billion.
Allergan plc is a specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of brand name pharmaceutical products, medical aesthetics, biosimilar and over-the-counter pharmaceutical products. The Company operates through three segments: US Specialized Therapeutics, US General Medicine and International. The US Specialized Therapeutics segment includes sales relating to branded products within the United States, including Medical Aesthetics, Medical Dermatology, Eye Care, Neurosciences and Urology therapeutic products. The US General Medicine segment includes sales relating to branded products within the United States that do not fall into the US Specialized Therapeutics business units, including Central Nervous System, Gastrointestinal, Women's Health, Anti-Infectives and Diversified Brands. The International segment includes sales relating to products sold outside the United States.
Spend a few minutes browsing the Allergan PLC, web site at http://www.allergan.com.